US FDA Approves OnabotulinumtoxinA for Platysma Bands
cutislaserclinics
0
14
Share this Post to earn Money ( Upto ₹100 per 1000 Views )
The US Food and Drug Administration (FDA) has approved Allergan’s OnabotulinumtoxinA for treating moderate to severe vertical platysma bands. The same injectable has been US FDA-proved for temporary improvement of the appearance of moderate to severe frown lines, forehead lines, and crow’s feet. The approval for platysma bands is the first beyond facial use and the fourth for aesthetic indication. Read More:
https://www.cutislaserclinics.com/blog/us-fda-approves-onabotulinumtoxina-for-platysma-bands/
